HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,173 | +12.5% | 62 | 0.0% | 0.00% | – |
| Q2 2023 | $6,377 | -5.8% | 62 | 0.0% | 0.00% | – |
| Q1 2023 | $6,767 | -4.1% | 62 | 0.0% | 0.00% | – |
| Q4 2022 | $7,056 | +135.2% | 62 | +24.0% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 50 | -18.0% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 61 | -34.4% | 0.00% | – |
| Q1 2022 | $10,000 | +100.0% | 93 | +86.0% | 0.00% | – |
| Q4 2021 | $5,000 | -28.6% | 50 | -16.7% | 0.00% | – |
| Q3 2021 | $7,000 | -75.9% | 60 | -80.6% | 0.00% | – |
| Q2 2021 | $29,000 | -100.0% | 310 | -81.8% | 0.00% | -100.0% |
| Q1 2021 | $156,468,000 | +381529.3% | 1,700 | +200.9% | 0.00% | 0.0% |
| Q4 2020 | $41,000 | -33.9% | 565 | -29.4% | 0.00% | -50.0% |
| Q3 2020 | $62,000 | +1140.0% | 800 | +841.2% | 0.00% | – |
| Q2 2020 | $5,000 | -94.1% | 85 | -97.1% | 0.00% | -100.0% |
| Q1 2020 | $85,000 | -19.8% | 2,885 | -1.7% | 0.00% | 0.0% |
| Q4 2019 | $106,000 | +32.5% | 2,935 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $80,000 | +5.3% | 2,965 | -7.1% | 0.00% | 0.0% |
| Q2 2019 | $76,000 | – | 3,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |